HAVCR1 and cancer: The overexpression of HAVcR-1 appeared to affect changes in the phosphorylation status of α and β-catenins, both of which are involved in cell motility and are part of the complex involved in HGF signalling, a key factor in the metastatic behaviour of cancer cells.